Skip to main content
37°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Enveric Biosciences, Inc. - Common Stock
(NQ:
ENVB
)
1.610
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.610
Bid (Size)
1.550 (2)
Ask (Size)
1.980 (1)
Prev. Close
1.610
Today's Range
1.610 - 1.610
52wk Range
1.130 - 420.75
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark
March 06, 2025
From
Enveric Biosciences
Via
Business Wire
Keep an eye on the top gainers and losers in Friday's session.
February 28, 2025
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Via
Chartmill
Performance
YTD
-98.17%
-98.17%
1 Month
+1.90%
+1.90%
3 Month
-98.00%
-98.00%
6 Month
-98.56%
-98.56%
1 Year
-99.40%
-99.40%
More News
Read More
These stocks have an unusual volume in today's session
February 28, 2025
Via
Chartmill
Enveric Biosciences CEO Issues Letter to Shareholders
February 27, 2025
From
Enveric Biosciences
Via
Business Wire
These stocks are moving in today's after hours session
February 26, 2025
Via
Chartmill
What's going on in today's session
February 26, 2025
Via
Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
February 26, 2025
Via
Chartmill
Dow Dips Over 100 Points; TJX Earnings Top Views
February 26, 2025
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Here are the top movers in Wednesday's session.
February 26, 2025
Via
Chartmill
Nasdaq Surges 150 Points; Lowe's Posts Upbeat Earnings
February 26, 2025
Via
Benzinga
Small-Caps Under $2 on the Move: ENVB, ONVO, TRNR, PRSO, PNPN.V Gaining Momentum
February 26, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Derivatives
Intellectual Property
Exposures
Artificial Intelligence
Derivatives
Intellectual Property
Traders are paying attention to the gapping stocks in Wednesday's session.
February 26, 2025
Via
Chartmill
These stocks are moving in today's pre-market session
February 26, 2025
Via
Chartmill
US Stocks Likely To Open Higher Ahead Of Nvidia Earnings: S&P 500's Four-Day Fall Was A 'Non-Event,' Says Expert
February 26, 2025
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
February 26, 2025
Via
Benzinga
Which stocks are moving after the closing bell on Tuesday?
February 25, 2025
Via
Chartmill
EXCLUSIVE: Non-Hallucinogenic Psychedelic Compounds Show Promise For Treating Addiction And ADHD
February 25, 2025
Via
Benzinga
Topics
Derivatives
Intellectual Property
Exposures
Derivatives
Intellectual Property
Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent
February 25, 2025
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Inks Two Licensing Agreements With Restoration Biologics To Treat Joint Disease
February 04, 2025
Via
Benzinga
Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease
February 04, 2025
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Announces Closing of $5 Million Public Offering
February 03, 2025
From
Enveric Biosciences, Inc.
Via
Business Wire
What's going on in today's session
January 31, 2025
Via
Chartmill
Dow Edges Lower; Exxon Mobil Earnings Top Views
January 31, 2025
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Which stocks are gapping on Friday?
January 31, 2025
Via
Chartmill
Nasdaq Jumps Over 150 Points; Apple Posts Upbeat Earnings
January 31, 2025
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.